Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
So, at Shea, we provide you with more than just a weight loss medication
According to NICE guidelines (NG28), GLP-1 receptor agonists may be considered for type 2 diabetes when metformin and other treatments have not achieved glycaemic targets
Low baseline ferritin and iron, zinc or vitamin D deficiency raise the risk
If initial therapy proves insufficient , healthcare professionals typically reassess the overall treatment plan rather than adding another weight loss medication
Analysts forecast that the obesity drug market will be worth $100 billion by 2030
Patent expiry is a natural part of the pharmaceutical product lifecycle, and we are well-positioned to navigate this evolving landscape, said Vikrant Shrotriya, Managing Director, Novo Nordisk India
US$ 26.45
US$ 28.29
US$ 24.39
US$ 21.62
US$ 25.94
US$ 26.29
US$ 24.96
